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Background: The epidemiological, pathophysiological and clinical links between upper and
lower airways are nowadays clearly demonstrated. Most of asthmatics are suffering from
rhinitis while up to 40% of rhinitic patients have asthma. Asthmatics and COPD patients are also
prone to develop concomitant chronic rhinosinusitis (CRS).
This study aimed to determine the predictive value of cough for concomitant asthma in
patients suffering from upper airway diseases.
Methods: This cross-sectional study described a group of 143 consecutive patients suffering
simultaneously from common upper and lower airway disorders. Both ENT-specialists and
respiratory physicians consecutively examined the patients in Ghent University Hospital from
October 2004 till October 2006. This study was based on the demographic characteristics,
upper and lower airway conditions.
Results: Forty-seven percent of the patients included in the study were males and the mean
age of studied population was 43.6 years. The major complaint was chronic cough. When
present, patients with chronic cough have an increased risk of suffering from a concomitant
asthma in both allergic rhinitis (ORZ 5.8) and CRS with nasal polyps (ORZ 10.4), but not in
CRS without polyps.
Conclusions: Chronic cough was found to be a key symptom of associated asthma in allergic
rhinitis and CRS with nasal polyps. Interestingly, chronic cough in CRS without nasal polyps
did not show the same predictive value: this suggests different pathophysiological mecha-
nisms.
ª 2009 Elsevier Ltd. All rights reserved.Introduction
Cough is an essential protective physiological mechanism
that prevents foods, liquids, dusts and chemicals from332 2332; fax: þ32 9 332 4993.
let@ugent.be (J.B. Watelet).
9 Elsevier Ltd. All rights reservedreaching the lower airways, but it is also a symptom of
many inflammatory diseases of the respiratory tract.1
Chronic cough, defined as lasting for more than
8 weeks,2,3 is reported by 3e40% of the general population3.
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study showed that 30% of the patients had nocturnal cough,
10% a productive cough and another 10% a non-productive
cough.5 Together with asthma and gastroesophageal reflux
disease.6 postnasal drip syndrome (PNDS) (induced by all
types of rhinitis and rhinosinusitis) is one the most common
causes of chronic cough.7 When considering all types of
cough, the upper airways cough syndrome (UACS), previ-
ously referred to as PNDS, has been shown to be the prin-
cipal cause of cough, especially when associated with
common cold,8 but this condition usually results in an acute
type of cough. When considering chronic cough, an etiology
can be determined in 88e100% of cases. This high rate of
accurate diagnosis implies a higher chance to successful
treatment.2
However, chronic cough can be related to more than one
disease. Three or more simultaneous causes have been
described in up to 42% of patients.9,10 Moreover, in patients
with chronic cough, neither the patient’s description of his
or her cough in terms of its character or timing, nor the
presence or absence of sputum production should be used
to rule in or rule out a diagnosis or to determine the clinical
approach.11
The difficulty in daily practice is to clinically differen-
tiate an upper airway cough syndrome from a chronic cough
generated by an associated lower airway disease.12,13 The
association of symptoms is of little clinical value and
physical findings are rarely conclusive.14
The aim of this study was to calculate the predictive
value of chronic cough for concomitant asthma in patients
suffering from upper airway diseases.
Materials and methods
Description of study
This cross-sectional study recruited consecutive outpa-
tients suffering from chronic upper airway symptoms. At
the moment of consultation, the patients should present
one or more lower airway symptoms for being included in
the study. They were systematically examined by both ENT-
specialists and pneumologists at the Ghent University
Hospital from October 2004 till October 2006. The data
collection was focused on demographic characteristics,
upper airway conditions, lower airway status, other co-
morbidities and smoking status. Both frequency and
severity of the upper and lower airway symptoms were
considered. The primary complaint was defined as the most
troublesome symptom or the symptom having led to
consultation. In the studied population, patients suffering
from chronic cough were distinguished from those without
chronic cough. Chronic cough was defined as cough lasting
for at least 8 weeks.2 Severity of cough was graded by the
patient into mild, moderate and severe. Mild was defined as
occurrence of symptom interfering neither with daily or
work activities nor with sleep. Moderate was considered if
interference with activities without necessity of treatment.
Severe was defined as the occurrence of symptom with
dependence of medication to function.
Allergic rhinitis was defined and classified into inter-
mittent or persistent following the ARIA classification15,16while asthma was defined and classified following the GINA
classification 1995.17 Asthma is defined as a chronic
inflammatory disorder of the airways in which many cells
and cellular elements play a role. The chronic inflammation
is associated with airway hyperresponsiveness that leads to
recurrent episodes of wheezing, breathlessness, chest
tightness, and coughing, particularly at night or in the early
morning. These episodes are usually associated with wide-
spread, but variable, airflow obstruction within the lung
that is often reversible either spontaneously or with
treatment. The clinical diagnosis of asthma was prompted
by symptoms such as episodic breathlessness, wheezing,
cough, and chest tightness. Measurements of lung function
(spirometry or peak expiratory flow) provided an assess-
ment of the severity of airflow limitation, its reversibility,
and its variability, and provided confirmation of the diag-
nosis of asthma. Asthma was classified by severity based on
the level of symptoms, airflow limitation, and lung function
variability into four categories: intermittent, mild persis-
tent, moderate persistent, or severe persistent. Chronic
rhinosinusitis with and without NP were defined following
the EAACI position paper EP3OS.18,19 The LundeMacKay
scores were used for staging abnormalities on CT scan of
sinuses. Gastroesophageal reflux (GER) was evoked when
a preliminary diagnosis was established by gastro-enter-
ologists or when symptoms of pyrosis, dysphagia were
present with endoscopic inflammation of the posterior
laryngeal commissure and with reduction of symptoms with
proton pump inhibitors.6,20 A complete otorhinolaryngo-
logical examination, CT scan of paranasal sinuses, allergy
tests (skin prick tests or RAST), chest auscultation and lung
function tests were performed in all patients for confir-
mation of the diagnosis.
Patients with pathologies such as vocal cord dysfunction,
chronic laryngitis, daily use of angiotensin-converting
enzyme inhibitors, post-intubation pharyngolaryngeal
pathology, and pharyngolaryngeal tumors were excluded
from this study.
The local Ethics Committee of the Ghent University
Hospital has been informed of the study.
Statistical analysis
For comparison of frequencies, the Chi-square test was
used in the univariate analysis; if the frequency in
a subgroup was lower than 5 the Fisher’s Exact test was
used. To calculate the odds ratios (ORs) a logistic regression
was used to determine the influence of independent vari-
ables on cough. Differences were regarded as statistically
significant if p < 0.05.
Results
A total of 143 consecutive patients were recruited for this
study, from which 12 were excluded for chronic laryngitis
(nZ 4), vocal cord dysfunction (nZ 3), daily use of
angiotensin-converting enzyme inhibitors (nZ 3), post-
intubation pharyngolaryngeal pathology (nZ 1), and
pharyngolaryngeal tumors (nZ 1). One hundred thirty-one
patients having concomitant nose and lung complaints were
finally considered as eligible for this study. The
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47% males, with a mean age of 43.6 years (range 16e
74 years) (Table 1).
Description of the most frequent upper and lower
airway symptoms
The most frequently reported complaints were cough, nasal
congestion, postnasal drip and rhinorrhea. Of the 131
patients, 58 (44.2%) experienced cough lasting more than
8 weeks as a main reason for consultation. Nasal congestion
was reported in 49.6% of the patients. Anterior rhinorrhea
and postnasal drip were found in 42.7% and 38.9% of
patients, respectively.
In the 58 patients with chronic cough, 55% were females.
The mean age was 46.4 years (range 16e83 years). The
most frequently associated symptoms within this group
were postnasal drip (41.3%), nasal congestion (39.6%) and
rhinorrhea (37.9%). In lesser extent, headache (25.8%),
sneezing (15.5%) and pharyngeal irritation (15.5%) were
present.
Severity of cough estimated by patient varied from
moderate to severe. Mild, moderate and severe cough were
found in 5.2%, 67.2%, and 27.6%, respectively. Only in
a minority of patients, there was nocturnal cough (20%)
with a mild to moderate grade of severity. A productive
cough was reported by 46.7%. If a productive cough was
present, the presence of purulence was equally distributed
(50% purulent and 50% non-purulent). No correlation was
found between chronic cough and patient’s feeling of
postnasal drip.Table 1 Demographic data, atopic status, lung function, serum
calculated in comparison with patients without the disease. *p <
Parameter Total (including GER) AR
n 131 66
Age: mean (range) 43.6 (16e74) 40
Gender ratio: males (%) 47 42
BMI: mean (range) 26.9 (17e37) 26
Smoking
Never (%) 65.4 70
Former (%) 23.5 20
Current (%) 11.1 9.
Total LundeMackay CT scan
sinus score: mean (range)
6.5 (0e12) 4.
Co-morbidities
Asthma (%) 53 57
Atopy (%) 57.6 10
After bronchodilator:
FEV1 abs 2.8 (1.5e4.2) 2.
FEV1% 85.2 (61e124) 85
FEV1/FVC 65.1 (44e88) 67
Mean (range)
Eosinophilia
Absolute 409 (10e2728) 39
Percent 5.1 (0.1e34) 5.
Mean (range)
Serum tot IgE mean (range) 476.4 (4.4e8170) 62Description of the most frequent upper and lower
airway diseases
Allergic rhinitis was present in 66 patients (50.3%). The most
frequent sensitization profiles were against house dust mites
(83%), pollens (56.9%) and pets (56.9%) isolated or in associa-
tion. CRS was found in 21 patients (16.0%), while NP was found
in 14 cases. The remaining patients, even if presenting upper
airway symptoms, were not found to have any chronic nasal or
sinus diseases but, in this group, endoscopic features of GER
were found in 15.2% of them. Patients with NP were found to
have significantly higher LundeMacKay CT scan scores than
those with CRS (pZ 0.01) or AR (p< 0.0001). In patients pre-
senting nasal disorders, up to 8.6% had associated GER.
Serum total IgE was found increased in AR when
compared to CRS and NP but the difference did not reach
a statistically significant difference. Finally, regarding the
serum absolute eosinophilia, AR and NP patients were
found with higher amount and trend for significant differ-
ence when compared with CRS (pZ 0.07 and pZ 0.08,
respectively). The percentage of serum eosinophilia was
not different between the groups even if the trend of
higher level in NP was found (Table 1).
At the level of lower airways, asthma was diagnosed in
55% of the patients. No significant difference concerning
absolute and percentage of FEV1 and FEV1/FVC scores was
observed between the groups. Chronic obstructive pulmo-
nary disease was found in three patients, and emphysema
in one. Bronchiectasis was diagnosed in 14 patients (11.3%),
from which three were diagnosed on lung X-rays and 11 on
high resolution CT scan.IgE concentrations and blood eosinophilia. The p-values are
0.0001 with AR and pZ 0.012 with CRS.
CRS NP
21 14
.9 (16e74) 48.9 (21e74) 48.7 (28e70)
.4 45 71.4
.7 (17e36) 28.5 (17e37) 25.2 (19e30)
.4 60 50
.4 33.3 25
2 6.7 25
7 (0e10) 5.4 (1e10) 16.0 (2e24)*
.6 30 71.4
0 30 42.8
8 (1.8e4.2) 2.3 (1.5e2.9) 3 (2.3e4.2)
.5 (61e124) 83.7 (69e98) 85.6 (65e101)
(44e88) 67.1 (59e76) 57.8 (44e77)
9.4 (10e2728) 360.9 (10e2143) 522.2 (40e2143)
2 (0.1e34) 4.1 (0.1e25) 6.3 (0.5e22)
2 (4.4e8170) 138.4 (4.8e525) 262.6 (13e889)
Table 2 Odd ratios (OR) and their confidence interval (CI)
for having concomitant asthma in patients suffering from
AR, CRS and NP with or without associated chronic cough.
NB: when in italics: not significant.
Patients Cough OR for
asthma (CI)
p-value
Allergic rhinitis No 3.3 (1.2e8.6) pZ 0.02
Yes 5.8 (1.7e19.6) pZ 0.005
Chronic rhinosinusitis
without NP
No 0.7 (0.2e2.2) pZ 0.6
Yes 0.3 (0.04e2.9) pZ 0.4
Chronic rhinosinusitis
with NP
No 2.0 (0.5e9.3) pZ 0.5
Yes 10.4 (11e100.8) pZ 0.03
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chronic cough in upper and lower airway diseases
In the chronic cough group, AR was present in 46.5% and
asthma in 31%. CRS was found in 12% of patients and NP in
8.6%.
Calculation of the predictive value of chronic cough
for concomitant asthma in patients suffering from
upper airway diseases
A patient with AR in absence of cough had a significant 3.2
higher risk of associated asthma than a patient without AR
(pZ 0.02). If cough was present concomitantly with AR,
the risk increased 5.8 fold higher than in patients without
AR and cough (pZ 0.004). Moreover, a patient with NP
without cough had a 2 fold higher risk of associated asthma
when compared to patients without NP (not significant)
while, in a patient with concomitant NP and chronic cough,
the risk to have concomitant asthma is 10 fold higher than
in patient without NP and cough (pZ 0.03) (Table 2).
Interestingly, chronic cough in CRS was not significantly
associated with higher percentage of concomitant asthma.
The sensitivity of chronic cough in AR for having
concomitant asthma reached 82% but poorly specific
(51.9%). The sensitivity and specificity of chronic cough in
the group of NP were respectively 77% and 80%. But, in this
group, the positive predictive value was 97.5% (Table 3).
Discussion
In this series of patients complaining of both upper and
lower airway symptoms, chronic cough was found to be the
most frequent reason for consulting. In this study, patients
with upper airway diseases when associated with chronic
cough were found to be more prone to have a concomitantTable 3 Sensitivity, specificity, positive and negative predictive
Patients Sensitivity
(%)
Specificit
(%)
Cough þ allergic rhinitis 84.4 51.9
Cough þ nasal polyposis 72.2 80.0asthma. Interestingly, this risk in association was different
in function of the upper airway disease: NP and AR associ-
ated with chronic cough are more likely to have a concom-
itant asthma when compared to CRS. These findings were in
line with the observed difference in eosinophilia between
the diseases. Considering the high positive predictive of
chronic cough, asking for cough should be considered as an
essential step during history taking in upper airways disor-
ders. All patients suffering from chronic upper airway
diseases and persistent cough should be systematically
screened for the presence of asthma.
The definition of chronic cough as lasting for more than
3 weeks9 includes often the post-infectious cough, which
has a benign course and requires mostly no treatment. As
a consequence, we preferred the definition stating that
cough should last for more than 8 weeks.2,3 In approxi-
mately 95% of cases in immunocompetent patients, chronic
cough results from asthma, conditions of the nose and
sinuses, gastroesophageal reflux disease, chronic bron-
chitis, bronchiectasis, eosinophilic bronchitis or the use of
angiotensin-converting enzyme inhibitors.2
When considering asthma, Dicpinigaitis reported that
asthma is present in 24e29% of non-smoker patients with
chronic cough and should be considered as potential
etiology in any of them.21 Moreover, cough can be the only
sign of asthma in up to 57% (cough variant asthma).2,22 On
the other hand, upper airway diseases are known to play
a role in asthma and rhinitis is considered as a risk factor for
asthma.15,23,24 Chronic rhinosinusitis is regularly associated
with asthma, particularly in adult-onset asthma25 and
severe steroid-dependent asthma.26
Regarding the participation of upper airways in chronic
cough, some data are also available. The differential
diagnosis of UACS includes isolated or associated sinusitis
and rhinitis (allergic, non-allergic, infectious, vasomotor,
drug- or irritant-induced).9,27 The exact role played by
chronic rhinosinusitis and its degree of involvement are still
debated. The major difficulties are linked to a poor speci-
ficity of symptoms11 and clinical signs.
Chronic rhinosinusitis is suspected as primary etiology in
8e81% of chronic cough patients.1 Kastelick et al. found
rhinosinusitis to be the causative factor in 80% of patients
with chronic cough,28 but another study claims that post-
nasal drip is the cause of chronic cough in up to 81% of
patients.29
However, as demonstrated in this study, patient’s
feeling of postnasal drip was not correlated with chronic
cough, as already suggested by O’Hara.30 A cobblestone
appearance of the oropharyngeal mucosa or presence of
mucoid secretions on the posterior pharyngeal wall are not
specific and not always present, even when a history of
postnasal drip is reported by the patient.31 Furthermore, it
has been suggested that chronic rhinosinusitis with orvalues of chronic cough as predictor for asthma.
y Positive predictive
value (%)
Negative predictive
value (%)
67.5 73.7
97.5 21.0
656 J.B. Watelet et al.without postnasal drip can cause coughing and may be
a marker of disease in the lower airways.3 In a question-
naire to patients with chronic rhinosinusitis or polyps,
Fokkens revealed that only 60% of them had postnasal drip,
whereas 74% coughed. In patients without asthma, the
figures dropped to 51% and 65%, respectively (unpublished
data, reported in 3). Finally, chronic cough has been also
described in the patient with AR, especially when AR is
associated with chronic rhinosinusitis.32
The pathogenesis of cough from UACS remains unclear
but there is a suspicion of mechanical stimulation of the
afferent limb of the cough reflex in the upper airway,
stimulation of cough receptors located in the hypopharynx
or larynx by aspirated secretions from the sinuses or a more
sensitive cough reflex in the upper airways.33,34 Airway wall
remodelling and local release of growth factors have been
suspected to heighten the cough reflex.35,36
Even if the study was performed on a population
recruited in a tertiary setting, this study supports the view
that chronic cough in upper airway diseases must be
considered as a marker of lower airway disorder. If, in
upper airway diseases, chronic cough possesses a positive
predictive value for having concomitant asthma, a differ-
ence in probability was observed between AR, CRS and NP.
Chronic cough in CRS was never found to be predictive of an
association with asthma. These findings suggest that the
nature of background inflammation should be determinant
in the occurrence of cough, especially of chronic cough.
This hypothesis was already proposed by ten Brike et al.,
when they described the involvement of eosinophils in this
process.26 Eosinophils are key effectors in the pathogenesis
of allergic rhinitis and chronic rhinosinusitis with NP, but
not in chronic rhinosinusitis without NP.37 Interestingly, in
our study, a trend of increased eosinophilia was found for
absolute eosinophilia in serum in both AR and NP when
compared to CRS. Further explorations taking into account
the local eosinophilia and the degree of eosinophil activa-
tion are requested.
Conclusions
In this cross-sectional analysis of patients with both upper
and lower airway symptoms, chronic cough was found to be
a key marker of associated asthma in AR and NP. Interest-
ingly, chronic cough in CRS did not show the same positive
predictive value. These findings suggest a different
inflammatory background or defensive mechanisms in this
condition. Finally, this study points out the importance of
a multidisciplinary approach of patients suffering from
concomitant upper and lower airway disorders.Acknowledgements
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